Summary information

Study title

Vaccines delivered onto mucosal surfaces: clinical trial with a nasal vaccine against influenza, 2001

Creator

Haneberg, Bjørn (Folkehelseinstituttet)

Study number / PID

https://doi.org/10.18712/NSD-NSD1180-V2 (DOI)

Data access

Information not available

Series

Not available

Abstract

Mucosal Vaccines are easier to provide and may cause less severe side effects. Experiments on mice have shown that a "killed" vaccine against influenza may give rise to strong immunity having been given as nose drops. Our findings in humans confirmed the earlier findings performed on mice. There was no effect in humans of so-called "adjuvants" or enhancers which are commonly used in vaccines. Nor was the effect of a drug used in nose drops to increase stickiness to mucous membranes.

Keywords

Not available

Methodology

Data collection period

Not available

Country

Time dimension

Not available

Analysis unit

Individual

Universe

Not available

Sampling procedure

Not available

Kind of data

Other

Data collection mode

Not available

Funding information

Funder

The Research Council of Norway

Access

Publisher

Sikt - Norwegian Agency for Shared Services in Education and Research

Publication year

2024

Terms of data access

Not available

Related publications

Not available